Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users

被引：4
|
作者：
Baud, Maxime O. [1 ]
Brown, Ethan G. [1 ]
Singhal, Neel S. [1 ,2 ]
Hemphill, J. Claude [1 ,2 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[2] San Francisco Gen Hosp, Dept Neurol, San Francisco, CA USA
来源：
STROKE | 2015年 / 46卷 / 07期
关键词：
cocaine; stroke; thrombolytic therapy; METAANALYSIS;
D O I：
10.1161/STROKEAHA.115.008687
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：e167 / e169
页数：3
相关论文
共 50 条
  • [21] Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model
    Kasahara, Yukiko
    Nakagomi, Takayuki
    Matsuyama, Tomohiro
    Stern, David
    Taguchi, Akihiko
    STROKE, 2012, 43 (02) : 499 - 506
  • [22] Hemorrhagic Transformation after Intravenous Tissue Plasminogen Activator Administration in Acute Distal Middle Cerebral Artery Occlusion
    Lee, Chan-Hyuk
    Yi, Sang Hak
    Shin, Byoung-Soo
    Kang, Hyun Goo
    DIAGNOSTICS, 2022, 12 (02)
  • [23] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TISSUE-TYPE PLASMINOGEN ACTIVATOR-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 COMPLEX ARE RECOGNIZED BY DIFFERENT RECEPTOR SYSTEMS IN THE LIVER
    KUIPER, J
    OTTER, M
    VANZONNEVELD, AJ
    RIJKEN, DC
    VANBERKEL, TJC
    CIRCULATION, 1993, 88 (04) : 366 - 366
  • [24] Intravenous tissue-type plasminogen activator for the treatment of acute ischemic stroke: The Spanish registry
    Davalos, A
    Alvarez-Sabin, J
    Marti-Vilalta, JL
    Castillo, J
    Molina, CA
    Marti-Fabregas, J
    Blanco, M
    Mostacero, E
    Vivancos, J
    Roquer, J
    Escudero, D
    Chamorro, A
    Leira, R
    Tejero, C
    Montaner, J
    Serena, J
    STROKE, 2003, 34 (01) : 280 - 280
  • [25] Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator More Proof That Time Is Brain
    Alberts, Mark J.
    CIRCULATION, 2017, 135 (02) : 140 - 142
  • [26] EFFECTIVENESS AND SAFETY OF A SINGLE INTRAVENOUS BOLUS INJECTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    HACKETT, D
    ANDREOTTI, F
    HAIDER, AW
    BRUNELLI, C
    SHAHI, M
    FUSSELL, A
    BULLER, N
    FOALE, R
    LIPKIN, D
    CAPONNETTO, S
    DAVIES, G
    MASERI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (17): : 1393 - 1398
  • [27] Reimbursement for Thrombectomy Devices in Patients Who Are Ineligible for Intravenous Tissue-Type Plasminogen Activator
    Broderick, Joseph P.
    Tomsick, Thomas A.
    STROKE, 2013, 44 (05) : 1215 - 1216
  • [28] Influence of Obesity on Effectiveness of Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke
    Schlick, Konrad
    Raman, Rema
    Hemmen, Thomas
    Meyer, Brett
    Meyer, Dawn
    Ernstrom, Karin
    Ovbiagele, Bruce
    NEUROLOGY, 2012, 78
  • [29] Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke
    Grond, M
    Rudolf, J
    Schmülling, S
    Stenzel, C
    Neveling, M
    Heiss, WD
    ARCHIVES OF NEUROLOGY, 1998, 55 (04) : 466 - 469
  • [30] ApoE phenotype and the effectiveness of intravenous tissue-type plasminogen activator in acute ischemic stroke
    Broderick, J
    Lu, M
    Jackson, C
    Pancioli, A
    Tilley, BC
    Fagan, SC
    Kothari, R
    Levine, SR
    Marler, JR
    Lyden, PD
    Haley, EC
    Brott, T
    Grotta, JC
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 421 - 421
12345